Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China flag China · Delayed Price · Currency is CNY
17.38
+0.37 (2.18%)
Apr 30, 2026, 1:55 PM CST

SHE:300246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
457.08676.95466.39498.72437.03336.55
Short-Term Investments
--263.97322.21342.83-
Trading Asset Securities
120.25-----
Cash & Short-Term Investments
577.33676.95730.35820.93779.86336.55
Cash Growth
-8.40%-7.31%-11.03%5.27%131.72%-30.33%
Accounts Receivable
246.55246.69262.44261.25297.24232.03
Other Receivables
11.329.9754.7227.5925.2226.26
Receivables
257.87256.67317.16288.84322.46258.29
Inventory
312.46287.82232.07220.37200.57193.5
Other Current Assets
65.3354.254.141.263341.41
Total Current Assets
1,2131,2761,3341,3711,336829.76
Property, Plant & Equipment
969.28957.12911.18888.73737.85584.72
Long-Term Investments
27.2827.5113.848.538.699.83
Goodwill
15.4915.4925.1540.67127.13127.13
Other Intangible Assets
104.28104.36101.6398.0894.5190.51
Long-Term Accounts Receivable
--4.125.59--
Long-Term Deferred Tax Assets
47.0340.6529.1918.132510.48
Long-Term Deferred Charges
39.642.5639.8140.8525.9131.85
Other Long-Term Assets
42.9558.9740.2162.4383.9735.24
Total Assets
2,4592,5222,4992,5342,4391,720
Accounts Payable
251.3224.01206.49246.8221.26178.44
Accrued Expenses
15.5624.7343.538.8749.5737.35
Short-Term Debt
114.39133.32188.14220.41132.64130.66
Current Portion of Long-Term Debt
304.18264.2840.750.3714.558.06
Current Portion of Leases
--6.656.455.954.47
Current Income Taxes Payable
4.424.471.983.083.983.37
Current Unearned Revenue
54.7749.1543.7569.3976.0148.08
Other Current Liabilities
85.77102.59144.61135.3499.4386.77
Total Current Liabilities
830.38802.54675.82770.7603.39497.2
Long-Term Debt
221.56306.89388.05284.16252.97205.21
Long-Term Leases
25.5520.3222.1923.6121.468.12
Long-Term Unearned Revenue
160.01167.89106.9450.345.389.32
Long-Term Deferred Tax Liabilities
14.8111.4414.7214.8713.487.25
Other Long-Term Liabilities
1.11.04-1.81-0.03
Total Liabilities
1,2531,3101,2081,145936.68727.13
Common Stock
264.61264.58264.58264.58175.79146.09
Additional Paid-In Capital
408.91408.11408.04408.03504.38-
Retained Earnings
423.21430.53513.04584.48684.82698.15
Treasury Stock
-20.01-20.01-20.01---
Comprehensive Income & Other
53.6854.3353.0453.8151.0949.64
Total Common Equity
1,1301,1381,2191,3111,416893.89
Minority Interest
75.174.6572.4378.0586.1798.49
Shareholders' Equity
1,2051,2121,2911,3891,502992.38
Total Liabilities & Equity
2,4592,5222,4992,5342,4391,720
Total Debt
665.68724.8645.72584.99427.57356.52
Net Cash (Debt)
-88.35-47.8684.63235.94352.29-19.97
Net Cash Growth
---64.13%-33.03%--
Net Cash Per Share
-0.33-0.180.320.891.35-0.09
Filing Date Shares Outstanding
264.22263.9261.6264.58263.68262.22
Total Common Shares Outstanding
264.22263.9261.6264.58263.68219.14
Working Capital
382.61473.1657.87600.7732.5332.56
Book Value Per Share
4.284.314.664.955.374.08
Tangible Book Value
1,0111,0181,0921,1721,194676.25
Tangible Book Value Per Share
3.823.864.174.434.533.09
Buildings
--582.36308.84244.21216.58
Machinery
--448.39418.44398.3361.28
Construction In Progress
--127.92365.74263.45155.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.